{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:44:04Z","timestamp":1790747044103,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The use of frequent electronic patient reported outcome measures (ePRO\u2019s) enables monitoring disease activity at a distance (telemonitoring) in patients with inflammatory arthritis. However, telemonitoring studies report declining long-term adherence to reporting ePRO\u2019s, which may oppose the benefits of telemonitoring. Therefore, the objective was to investigate what factors are associated with (non-)adherence to telemonitoring with a weekly ePRO in patients with inflammatory arthritis (IA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a prospective cohort study in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) at Reade Amsterdam, The Netherlands. Patients telemonitored their disease activity weekly for 6\u00a0months with a modified Multidimensional Health Assessment Questionnaire completed in a smartphone application. The primary outcome was time to dropout, defined as\u2009\u2265\u20094\u00a0weeks of consecutively nonresponse. Based on literature and through expert meetings, a predefined set of 13 baseline factors were selected to assess the association with time to dropout through a multivariable Cox-regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 220 consecutive patients were included (mean age 54, SD 12; 55% females; 99 RA, 81 PsA, and 40 AS). A total of 141 patients (64%) dropped out, with a median time to dropout of 17\u00a0weeks (IQR 9\u201326). Women had a significant higher chance to dropout over 6\u00a0months compared to men (HR 1.58, 95% CI 1.06\u20132.36).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In the set of investigated factors, women stopped reporting the weekly ePRO sooner than men. Future focus group discussions will be performed to investigate the reasons for dropout, and in specific why women dropped out sooner.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> This trials was prospectively registered at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.trialregister.nl\">www.trialregister.nl<\/jats:ext-link> (NL8414).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41927-022-00303-w","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T06:43:45Z","timestamp":1669790625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Who stop telemonitoring disease activity and who adhere: a prospective cohort study of patients with inflammatory arthritis"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9073-7388","authenticated-orcid":false,"given":"J.","family":"Wiegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. F.","family":"Seppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Nurmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"ter Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"issue":"6","key":"303_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e9 RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685\u201399.","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 101","key":"303_CR2","first-page":"S40","volume":"34","author":"PL van Riel","year":"2016","unstructured":"van Riel PL, Renskers L. The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(5 Suppl 101):S40\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"5 Suppl 85","key":"303_CR3","first-page":"S-75","volume":"32","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Aletaha D. Scores for all seasons: SDAI and CDAI. Clin Exp Rheumatol. 2014;32(5 Suppl 85):S-75-9.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"303_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/acr.23280","volume":"70","author":"A de Thurah","year":"2018","unstructured":"de Thurah A, Stengaard-Pedersen K, Axelsen M, Fredberg U, Schougaard LMV, Hjollund NHI, et al. Tele-health followup strategy for tight control of disease activity in rheumatoid arthritis: results of a randomized controlled trial. Arthritis Care Res. 2018;70(3):353\u201360.","journal-title":"Arthritis Care Res"},{"key":"303_CR5","doi-asserted-by":"crossref","unstructured":"Seppen BW J, ter Wee M,; van Schaardenburg D, Roorda L, Nurmohamed M, Bos W. Smartphone assisted patient initiated care safely reduces outpatient clinic visits in patients with rheumatoid arthritis: results from a randomized controlled trial. Arthritis Rheumatol. 2021;73.","DOI":"10.1002\/art.42292"},{"issue":"1","key":"303_CR6","doi-asserted-by":"publisher","first-page":"e001566","DOI":"10.1136\/rmdopen-2021-001566","volume":"7","author":"Y Shaw","year":"2021","unstructured":"Shaw Y, Courvoisier DS, Scherer A, Ciurea A, Lehmann T, Jaeger VK, et al. Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction. RMD Open. 2021;7(1):e001566.","journal-title":"RMD Open."},{"issue":"11","key":"303_CR7","doi-asserted-by":"publisher","first-page":"e399","DOI":"10.2196\/jmir.8598","volume":"19","author":"AL Rathbone","year":"2017","unstructured":"Rathbone AL, Clarry L, Prescott J. Assessing the efficacy of mobile health apps using the basic principles of cognitive behavioral therapy: systematic review. J Med Internet Res. 2017;19(11):e399.","journal-title":"J Med Internet Res"},{"issue":"2","key":"303_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/rheumatology\/kez207","volume":"59","author":"L Austin","year":"2020","unstructured":"Austin L, Sharp CA, van der Veer SN, Machin M, Humphreys J, Mellor P, et al. Providing \u201cthe bigger picture\u201d: benefits and feasibility of integrating remote monitoring from smartphones into the electronic health record. Rheumatology. 2020;59(2):367\u201378.","journal-title":"Rheumatology"},{"issue":"1","key":"303_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13063-019-3272-0","volume":"20","author":"CO Bingham 3rd","year":"2019","unstructured":"Bingham CO 3rd, Gaich CL, DeLozier AM, Engstrom KD, Naegeli AN, de Bono S, et al. Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation. Trials. 2019;20(1):182.","journal-title":"Trials"},{"issue":"8","key":"303_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/art.41686","volume":"73","author":"YC Lee","year":"2021","unstructured":"Lee YC, Lu F, Colls J, Luo D, Wang P, Dunlop DD, et al. Outcomes of a mobile app to monitor patient-reported outcomes in rheumatoid arthritis: a randomized controlled trial. Arthritis Rheumatol. 2021;73(8):1421\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"303_CR11","doi-asserted-by":"publisher","first-page":"e20165","DOI":"10.2196\/20165","volume":"4","author":"BF Seppen","year":"2020","unstructured":"Seppen BF, Wiegel J, L\u2019Ami MJ, Dos Santos Rico SD, Catarinella FS, Turkstra F, et al. Feasibility of self-monitoring rheumatoid arthritis with a smartphone app: results of two mixed-methods pilot studies. JMIR Formative Res. 2020;4(9):e20165.","journal-title":"JMIR Formative Res"},{"key":"303_CR12","doi-asserted-by":"crossref","unstructured":"Venkatesh V, Morris MG, Davis GB, Davis FD. User acceptance of information technology: toward a unified view. MIS Q. 2003:425\u201378.","DOI":"10.2307\/30036540"},{"issue":"3","key":"303_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2307\/249008","volume":"13","author":"FD Davis","year":"1989","unstructured":"Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q. 1989;13(3):319\u201340.","journal-title":"MIS Q"},{"issue":"19","key":"303_CR14","doi-asserted-by":"publisher","first-page":"10161","DOI":"10.3390\/ijerph181910161","volume":"18","author":"J Wiegel","year":"2021","unstructured":"Wiegel J, Seppen B, van der Leeden M, van der Esch M, de Vries R, Bos W. Adherence to telemonitoring by electronic patient-reported outcome measures in patients with chronic diseases: a systematic review. Int J Environ Res Public Health. 2021;18(19):10161.","journal-title":"Int J Environ Res Public Health."},{"issue":"1","key":"303_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/rheumatology\/keaa202","volume":"60","author":"J Colls","year":"2021","unstructured":"Colls J, Lee YC, Xu C, Corrigan C, Lu F, Marquez-Grap G, et al. Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritis. Rheumatology. 2021;60(1):108\u201312.","journal-title":"Rheumatology"},{"issue":"8","key":"303_CR16","doi-asserted-by":"publisher","first-page":"e033321","DOI":"10.1136\/bmjopen-2019-033321","volume":"10","author":"L Renskers","year":"2020","unstructured":"Renskers L, Rongen-van Dartel SA, Huis AM, van Riel PL. Patients\u2019 experiences regarding self-monitoring of the disease course: an observational pilot study in patients with inflammatory rheumatic diseases at a rheumatology outpatient clinic in The Netherlands. BMJ Open. 2020;10(8):e033321.","journal-title":"BMJ Open"},{"issue":"2","key":"303_CR17","doi-asserted-by":"publisher","first-page":"e15105","DOI":"10.2196\/15105","volume":"9","author":"BF Seppen","year":"2020","unstructured":"Seppen BF, L\u2019Ami MJ, Dos Santos Rico SD, ter Wee MM, Turkstra F, Roorda LD, et al. A smartphone app for self-monitoring of rheumatoid arthritis disease activity to assist patient-initiated care: protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9(2):e15105.","journal-title":"JMIR Res Protoc"},{"issue":"5 Suppl 101","key":"303_CR18","first-page":"S17","volume":"34","author":"T Pincus","year":"2016","unstructured":"Pincus T. Electronic multidimensional health assessment questionnaire (eMDHAQ): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring of long-term outcomes. Clin Exp Rheumatol. 2016;34(5 Suppl 101):S17-s33.","journal-title":"Clin Exp Rheumatol"},{"key":"303_CR19","unstructured":"ISO\/IEC 27001:2013. Available from: https:\/\/www.iso.org\/standard\/54534.html."},{"issue":"6","key":"303_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/asi.20801","volume":"59","author":"HL O'Brien","year":"2008","unstructured":"O\u2019Brien HL, Toms EG. What is user engagement? A conceptual framework for defining user engagement with technology. J Am Soc Inform Sci Technol. 2008;59(6):938\u201355.","journal-title":"J Am Soc Inform Sci Technol"},{"issue":"11","key":"303_CR21","doi-asserted-by":"publisher","first-page":"e22212","DOI":"10.2196\/22212","volume":"8","author":"AK B\u00f6hm","year":"2020","unstructured":"B\u00f6hm AK, Jensen ML, S\u00f8rensen MR, Stargardt T. Real-world evidence of user engagement with mobile health for diabetes management: longitudinal observational study. JMIR Mhealth Uhealth. 2020;8(11):e22212.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"9","key":"303_CR22","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3899\/jrheum.090363","volume":"36","author":"N Santesso","year":"2009","unstructured":"Santesso N, Rader T, Wells GA, O\u2019Connor AM, Brooks PM, Driedger M, et al. Responsiveness of the effective consumer scale (EC-17). J Rheumatol. 2009;36(9):2087\u201391.","journal-title":"J Rheumatol"},{"issue":"1","key":"303_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pec.2011.07.017","volume":"87","author":"PM ten Klooster","year":"2012","unstructured":"ten Klooster PM, Oostveen JC, Zandbelt LC, Taal E, Drossaert CH, Harmsen EJ, et al. Further validation of the 5-item Perceived Efficacy in Patient-Physician Interactions (PEPPI-5) scale in patients with osteoarthritis. Patient Educ Couns. 2012;87(1):125\u201330.","journal-title":"Patient Educ Couns"},{"issue":"6","key":"303_CR24","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.chb.2013.06.006","volume":"29","author":"LD Rosen","year":"2013","unstructured":"Rosen LD, Whaling K, Carrier LM, Cheever NA, Rokkum J. The Media and Technology Usage and Attitudes Scale: An empirical investigation. Comput Human Behav. 2013;29(6):2501\u201311.","journal-title":"Comput Human Behav"},{"issue":"6","key":"303_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/10447310802205776","volume":"24","author":"A Bangor","year":"2008","unstructured":"Bangor A, Kortum PT, Miller JT. An empirical evaluation of the system usability scale. Int J Hum Comput Interact. 2008;24(6):574\u201394.","journal-title":"Int J Hum Comput Interact"},{"issue":"5","key":"303_CR26","doi-asserted-by":"publisher","first-page":"e15815","DOI":"10.2196\/15815","volume":"4","author":"T Pincus","year":"2020","unstructured":"Pincus T, Castrejon I, Riad M, Obreja E, Lewis C, Krogh NS. Reliability, feasibility, and patient acceptance of an electronic version of a multidimensional health assessment questionnaire for routine rheumatology care: validation and patient preference study. JMIR Formative Res. 2020;4(5):e15815.","journal-title":"JMIR Formative Res"},{"issue":"5","key":"303_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"key":"303_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/1471-2474-14-286","volume":"14","author":"LD Hughes","year":"2013","unstructured":"Hughes LD, Done J, Young A. A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs. BMC Musculoskelet Disord. 2013;14:286.","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"303_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1207\/s15327906mbr2603_7","volume":"26","author":"SB Green","year":"1991","unstructured":"Green SB. How many subjects does it take to do a regression analysis. Multivariate Behav Res. 1991;26(3):499\u2013510.","journal-title":"Multivariate Behav Res"},{"issue":"13","key":"303_CR30","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1177\/0961203315585814","volume":"24","author":"Y Jamilloux","year":"2015","unstructured":"Jamilloux Y, Sarabi M, Kerever S, Boussely N, le Sidaner A, Valgueblasse V, et al. Adherence to online monitoring of patient-reported outcomes by patients with chronic inflammatory diseases: a feasibility study. Lupus. 2015;24(13):1429\u201336.","journal-title":"Lupus."},{"issue":"3","key":"303_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/tmj.2012.0096","volume":"19","author":"JR Guzman-Clark","year":"2013","unstructured":"Guzman-Clark JR, van Servellen G, Chang B, Mentes J, Hahn TJ. Predictors and outcomes of early adherence to the use of a home telehealth device by older veterans with heart failure. Telemed J E-Health. 2013;19(3):217\u201323.","journal-title":"Telemed J E-Health"},{"issue":"11","key":"303_CR32","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.amjmed.2017.07.007","volume":"130","author":"D Rosen","year":"2013","unstructured":"Rosen D, McCall JD, Primack BA. Telehealth protocol to prevent readmission among high-risk patients with congestive heart failure. Am J Med. 2013;130(11):1326\u201330.","journal-title":"Am J Med."},{"issue":"4","key":"303_CR33","first-page":"559","volume":"33","author":"R L\u00f3pez-Gonz\u00e1lez","year":"2015","unstructured":"L\u00f3pez-Gonz\u00e1lez R, Le\u00f3n L, Loza E, Redondo M, Garcia de Y\u00e9benes MJ, Carmona L. Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review. Clin Exp Rheumatol. 2015;33(4):559\u201369.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"303_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/annrheumdis-2021-221163","volume":"81","author":"A Balsa","year":"2022","unstructured":"Balsa A, de Y\u00e9benes MJG, Carmona L. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study. Ann Rheum Dis. 2022;81(3):327\u201334.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"303_CR35","first-page":"079","volume":"5","author":"WD M\u00fcskens","year":"2021","unstructured":"M\u00fcskens WD, Rongen-van Dartel SAA, Vogel C, Huis A, Adang EMM, van Riel P. Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization. Rheumatol Adv Pract. 2021;5(1):079.","journal-title":"Rheumatol Adv Pract"},{"issue":"8","key":"303_CR36","doi-asserted-by":"publisher","first-page":"e19661","DOI":"10.2196\/19661","volume":"8","author":"J Knitza","year":"2020","unstructured":"Knitza J, Simon D, Lambrecht A, Raab C, Tascilar K, Hagen M, et al. Mobile health usage, preferences, barriers, and ehealth literacy in rheumatology: patient survey study. JMIR Mhealth Uhealth. 2020;8(8):e19661.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"9","key":"303_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41584-020-0461-x","volume":"16","author":"DH Solomon","year":"2020","unstructured":"Solomon DH, Rudin RS. Digital health technologies: opportunities and challenges in rheumatology. Nat Rev Rheumatol. 2020;16(9):525\u201335.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"303_CR38","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.2196\/jmir.2104","volume":"14","author":"SM Kelders","year":"2012","unstructured":"Kelders SM, Kok RN, Ossebaard HC, Van Gemert-Pijnen JE. Persuasive system design does matter: a systematic review of adherence to web-based interventions. J Med Internet Res. 2012;14(6):e152.","journal-title":"J Med Internet Res"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-022-00303-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-022-00303-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-022-00303-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T06:49:50Z","timestamp":1669790990000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-022-00303-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1186\/s41927-022-00303-w","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is performed in accordance with legislation, and approved by the medical ethics committee of the Vrije Universiteit medisch centum (VUmc) at Amsterdam, the Netherlands (case number 2019.641). They issued a waiver for written informed consent for this study, and approved electronic informed consent as mentioned above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}